Dr. Hemant Thacker General Physician in Mumbai

Dr. Hemant Thacker

General Physician, Mumbai

MBBS, MD

  • 3 Hospitals

About

  • Head of Department, Bhatia General Hospital, Mumbai, India.
  • A consultant physician with Mumba-based Jaslok Hospital, Breach Candy Hospital and Saifee Hospital
  • Medical Advisor- Times Of India, Tata Chemicals Ltd, Indian Organic Chem, Mafatlal Industries, Merill Lynch
  • Chief Medical Advisor- Forbes Gokak Ltd, Exxon Mobil Shipping Division. (Navigation Medicine)
  • Medical Consultant-Mondial Assistance (a Paris- based International Insurance & Health Organization)
  • Consultant – Medical Affairs- Charak Ayurveda Pharma

Specialities

  • General Medicine

Expertise

Education

  • MBBS, Seth GS Medical College and KEM Hospital, 1978
  • MD, Medicine and Therapeutics, KEM Hospital, 1982

Practice Information

Breach Candy Hospital, Mumbai

Breach Candy Hospital, Mumbai

60-A, Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Bhatia General Hospital, Mumbai

Bhatia General Hospital, Mumbai

Tardeo Road, Mumbai, Maharashtra - 400007

Jaslok Hospital And Medical Research Institute, Mumbai

Jaslok Hospital And Medical Research Institute, Mumbai

15, Dr.G.Deshmukh Marg, Pedder Road, Mumbai, Maharashtra - 400026

Achievements & Contributions

  • Efficacy of S-amlodipine in normotensive angina patients – Journal of Indian Medical Association; April 2007.
  • A double blind study to determine the clinical efficacy of chirally pure pantoprozole in comparison with racemic pantoprozole- Published in Indian Journal of Gastro-Enterology; 2007.
  • HDL Increasing Strategies –   Chapter written in The Association of Physicians of India Textbook of Medicine; 2008.
  • Blood Pressure control in Diabetic Patients – Chapter written in The Association of Physicians of India Textbook of Medicine; 2009.
  • Management of Hypertension with The Fixed Combination of Perindopril and Amlodipine in Daily Clinical Practice – American Journal of Cardiovascular Drugs; 2009.
  • Effects of a polypill on risk factors in middle-aged individuals without  cardiovascular disease (TIPS): A phase II, double-blind, randomized trial;  Lancet-on-line; March, 2009.
  • Authored a chapter on the treatment of Dyslipidemia in the API Textbook of Medicine; 2009 – 2010.
-->